Research graph
References from Association of Post-Dexamethasone Cortisol With Cardiovascular and Metabolic Comorbidities in Patients With Nonfunctioning Adrenal Adenomas. Local targets link to admitted publications; unresolved targets remain external evidence.
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
10.1093/ejendo/lvad066 · 2023 · External reference
The Landmark Series: Evaluation and Management of Adrenal Incidentalomas
10.1245/s10434-025-17296-8 · 2025 · External reference
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis
10.1093/ejendo/lvad134 · 2023 · External reference
Cardiometabolic comorbidities and cardiovascular events in “non-functioning” adrenal incidentalomas: a systematic review and meta-analysis
10.1007/s40618-024-02440-0 · 2024 · External reference
Cardiometabolic Risk Parameters in “Nonfunctioning” Adrenal Incidentalomas: A Systematic Review and Meta-analysis
10.1210/clinem/dgaf597 · 2026 · External reference
Mortality in Patients With Nonfunctional Adrenal Tumors
10.1001/jamainternmed.2023.2442 · 2023 · External reference
Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 μg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 μg/dL
10.1007/s12020-022-03228-z · 2023 · External reference
The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors
10.1186/s12933-023-01836-1 · 2023 · External reference
Lowering the dexamethasone suppression test cut-off: is it time yet?
10.1007/s40618-025-02679-1 · 2025 · External reference
Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study
10.1016/s2213-8587(26)00098-7 · 2026 · External reference
Unresolved reference
External reference
10.1161/circulationaha.109.192644
10.1161/circulationaha.109.192644 · 2009 · External reference
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026
2026 · External reference
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
10.1093/eurheartj/ehaf190 · 2025 · External reference
The clinician’s guide to prevention and treatment of osteoporosis
10.1007/s00198-021-05900-y · 2022 · External reference
Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a systematic review and meta-analysis
10.1186/s12902-025-01923-2 · 2025 · External reference
Prevalence and incidence of diabetes in patients with non-functional adrenal tumors
2026 · External reference
Dynamic testing of cortisol in consecutive patients with suspected adrenal disorders: a comparison of Elecsys Cortisol II and LC-MS/MS
10.1530/ec-25-0600 · 2026 · External reference
Metabolic syndrome and Visceral Adiposity Index in non-functional adrenal adenomas
2023 · External reference
Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review
10.1210/clinem/dgad453 · 2024 · External reference
Prevalence and incidence of fractures in patients with nonfunctional adrenal tumors
10.1001/jamanetworkopen.2024.6453 · 2024 · External reference
Fracture risk by cortisol excess status in patients with adrenal incidentalomas: a population-based cohort study
10.1093/jbmrpl/ziaf043 · 2025 · External reference
